The
peptides market is worth $14.1Bn and is growing at an average CAGR of 8.7%. The market is forcasted to grow to $25.5Bn at the end of 2018. The market will grow due to the explosion of non communicable diseases such as metabolic and cardiovascular diseases that that have become endemic in our society.
Peptide technology has been growing at an impressive rate with enhancements in synthesis mechanisms such as solid and liquid phase synthesis. There has also been an impressive growth in the cancer peptide market with a CAGR of 9.4%. Currently the peptide market makes up only 1.55% of the overall market, but this is expected to change thanks to new technologies and the increased number of peptides in the pipeline with 120 in the clinical trial phase and 600 in the preclinical stage.
We proudly present our
2nd Annual conference on Peptides taking place on 8th & 9th July 2015 in London. The conference sets the stage for attendees to gain valuable insight into innovative topics such as Cyclic
Peptides: R&D platforms, manufacture and stability, Oral Delivery of
peptides, Cell permeable peptide therapeutics for cancer treatments and Development of
Peptides for the Clinic. Along with this, the programme will provide insight into Formulating Solutions for Delivery and round table discussions on case studies demonstrating the translation of R&D
peptides to the clinic.
Benefits of Attending
- ENHANCE understandings of current peptide R&D platforms to allow for rapid and efficient discovery of new compounds.
- GAIN a greater insight into oral delivery mechanisms to allow for greater access to the clinic and increased patient compliance.
- LEARN how to translate R&D from the bench to the clinic to ensure smooth transitions.
- EXPAND Familiarity about current peptide synthesis mechanisms and gain an insight into what technologies are available to synthesise peptides in an effective manner.
- DEVELOP knowledge on the latest breakthrough peptide therapeutics and first in class drugs to treat non-communicable diseases.
Plus an Interactive Half-Day Pre-Conference PM Workshop | Tuesday 7th July 2015
Cyclic Peptides: Discovery, Development and DeploymentWorkshop Leader: Roger new, CSO, diabetology
1.30 – 5.45pm
Speakers
- Alexandra Matzke-Ogi, CSO, Amcure
- Ali Tavassoli, Reader in Chemical Biology, University Of Southampton
- Anna-Karin Lundback, Scientist I, MedImmune
- Chiara Valenzano, Principal Scientist, UCB Celltech
- Dan Teufel, Head of Chemsitry, Bicycle Therapeutics Limited
- David Brayden, Professor of advanced drug delivery, University College Dublin
- James Mason, Senior Lecturer, Kings College London
- Joerg Vollmer, CEO, Nexigen GmbH
- Juan J Diaz-Mochon, Ramon y Cajal Fellow, GENYO
- Lutz Jermutus, Senior Director, R&D & Product Development Team Leader, MedImmune
- Mande Holford, Assistant Professor, Hunter College/ American Museum of Natural History
- Mark Howard, Reader in Biological NMR Spectroscopy, University Of Kent
- Peter Scott, Professor of Chemistry, University of Warwick
- Renata Zbozien, Research Manager, Haemostatix Ltd
- Roger New, Co-founder & CSO, Proxima Concepts Ltd
- Rosario Sanchez-Martin, Group Leader of NANOCHEMBIO research team, GENYO
- Stephen Hale, Senior Vice President, Biological Sciences, Ensemble Therapeutics
Please fill in your name and email to receive the conference agenda of this event.
The agenda is available as PDF under downloads at the right side of the page.
Venue
The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.
Who Should Attend
- Laboratory Head
- Research Associate
- CEO
- CSO
- Head of Late Discovery
- Director of Peptide and Protein Chemistry
- Head of Peptide Chemistry
- Investigator III
- Investigator II
- Strategic Marketing Director
- Manufacturing Director
- Peptide Discovery Group, Exploratory Medicinal Chemistry Unit
- Fellow
- Associate Scientist
- BDM
- Associate Director
- Director of Chemistry
- Formulation Scientist
- Principle RA
- Marketing and Advertising Coordinator
- Communication Manager
- Technical Sales
- Senior Scientist
Venue
Marriott Hotel, Regents Park128 King Henry's Road
London, NW3 3ST
United Kingdom
